Additionally, we analyzed ABCC1 inhibition with Cediranib, a VEGF receptor tyrosine kinase inhibitor, described in one study to have inhibitory effects on ABCC1 in human carcinoma cell lines26. The gene discussed is ABCC1; the disease is carcinoma.